CDK2 and non-small cell lung carcinoma: The knockdown of YTHDF1 inhibited cell proliferation of NSCLC by managing the translational efficiency of cyclin D1 (CCND1), cyclin-dependent kinase 2 (CDK2) and cyclin-dependent kinase 4 (CDK4).